Singapore markets open in 4 hours 23 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,079.50 +1,739.64 (+3.03%) CMC Crypto 200
1,278.15 +7.40 (+0.58%)
ABT Jun 2025 125.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:39PM EDT. Market open.
| Previous close | 4.3500 |
| Open | 4.4500 |
| Bid | 2.7200 |
| Ask | 4.0000 |
| Strike | 125.00 |
| Expiry date | 2025-06-20 |
| Day's range | 4.3500 - 4.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | 154 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.